Morning Read: Unapproved stem cell tests abound, an artificial pancreas on the horizon – MedCity News
MedCity News |
Morning Read: Unapproved stem cell tests abound, an artificial pancreas on the horizon
MedCity News More than 300 companies are selling unapproved stem cell tests and procedures in the U.S., according to a study published in the journal Cell Stem Cell. — Reuters. Medtronic has filed for premarket approval for an artificial pancreas that, if approved … |
